These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 414875)

  • 21. [Hydergin therapy of cerebrovascular insufficiency in patients requiring digitalis. Results of a double-blind study (author's transl)].
    Dennler HJ; Bachmann H
    MMW Munch Med Wochenschr; 1979 Nov; 121(48):1615-8. PubMed ID: 118360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of organic psychosyndrome with hydergine and digitalis. A component study using double blind technics].
    Pfeiff E; Schlegel HE; Seus R; Dennler HJ; Kugler J
    Med Welt; 1980 Sep; 31(39):1403-7. PubMed ID: 7005587
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of a levo-5-hydroxytryptophan-dihydroergocristine combination on depression and neuropsychic performance: a double-blind placebo-controlled clinical trial in elderly patients.
    Rousseau JJ
    Clin Ther; 1987; 9(3):267-72. PubMed ID: 3111702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [CDP choline in cerebral vasculopathy: clinical evaluation and instrumental semeiology].
    Corso EA; Arena M; Ventimiglia A; Bizzarro G; Campo G; Rodolico F
    Clin Ter; 1982 Aug; 102(4):379-86. PubMed ID: 6754218
    [No Abstract]   [Full Text] [Related]  

  • 25. [A double-blind controlled clinical study on the use of mucopolysaccharides in the treatment of patients with cerebral vasculopathy. Comparison with a placebo].
    Bardin P; Campo R
    Clin Ter; 1987 Jan; 120(2):111-8. PubMed ID: 2972439
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of the association of raubasine and dihydroergocristine in the aged patient with vascular disease].
    Sauter R
    Lille Med; 1971; 17():Suppl 3:551-8. PubMed ID: 5005074
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current trends in drug therapy of cerebral ictus].
    Foglia M; Repaci G; Mazzei V; Carulli E; Mapelli A
    Arch Sci Med (Torino); 1978; 135(3):417-22. PubMed ID: 708093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dihydroergocristine in the treatment of organic brain psychosyndrome. Dose-finding study against placebo].
    Milvio C
    Arzneimittelforschung; 1992 Nov; 42(11A):1399-402. PubMed ID: 1492861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical studies on the use of gangliosides in acute cerebrovascular diseases].
    Lipparini R; Broccoli PL; Albini U; Pangia A
    Minerva Med; 1975 Oct; 66(72):3774-84. PubMed ID: 1103014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Card-Hydergin for treatment of heart insufficiency in elderly patients with cerebrovascular deficiency].
    Schmidt W
    ZFA (Stuttgart); 1977 Mar; 53(8):447-52. PubMed ID: 324165
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of the therapeutic effectiveness of a piracetam plus dihydroergocristine combination in the treatment of vertigo].
    López Martínez R
    Acta Otorrinolaringol Esp; 1988; 39(4):287-8. PubMed ID: 3152560
    [No Abstract]   [Full Text] [Related]  

  • 32. [Quantitative rheographic study of the effects of a new drug combination: raubasine/dihydroergocristine].
    Henriet M; Jacquy J; Noel G
    Brux Med; 1974 Dec; 54(12):743-5. PubMed ID: 4215548
    [No Abstract]   [Full Text] [Related]  

  • 33. [Long-term treatment of cerebrovascular changes in the elderly (author's transl)].
    Kugler J; Oswald WD; Herzfeld U; Seus R; Pingel J; Welzel D
    Dtsch Med Wochenschr; 1978 Mar; 103(11):456-62. PubMed ID: 631030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cosaldon for vascular disorders?
    Drug Ther Bull; 1972 Aug; 10(17):66-8. PubMed ID: 4570865
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ginkgo-biloba in the therapy of vascular diseases].
    Sorbini E
    Minerva Med; 1973 Nov; 64(79 Suppl):4201-8. PubMed ID: 4592298
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
    Florio F; Ruffolo S; Piro E
    Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of the effectiveness of dihydroergotoxine (DHET) in the treatment of chronic cerebral ischemia syndromes in elderly patients].
    Derejczyk J; Panuś K
    Wiad Lek; 1986 Jun; 39(12):818-24. PubMed ID: 3535261
    [No Abstract]   [Full Text] [Related]  

  • 38. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
    Predescu V; Giurezu T; Tudorache D; Nica S; Ionescu R; Nicolschi L; Nitrurad A; Popvici E; Curelaru S
    Act Nerv Super (Praha); 1974 Aug; 16(3):237-8. PubMed ID: 4214302
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of organic brain psychosyndrom in the old age. A double blind study with Hydergin (author's transl)].
    Biel ML; Seus R; Struppler A
    Med Klin; 1976 Dec; 71(49):2177-84. PubMed ID: 794665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.